玻璃体黄斑牵引综合征的治疗及研究进展  

Treatment and research progress of vitreous macular traction syndrome

作　　者：吴璞成 郭菊 金学民[1] Wu Pucheng;Guo Ju;Jin Xuemin(Department of Ophthalmology,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Department of Ophthalmology,Tianjin Medical University General Hospital,Tianjin 300052,China)

机构地区：[1]郑州大学第一附属医院眼科,郑州450052 [2]天津医科大学总医院眼科,天津300052

出　　处：《中华眼外伤职业眼病杂志》2024年第11期874-880,共7页Chinese Journal of Ocular Trauma and Occupational Eye Disease

摘　　要：由于残存玻璃体对黄斑的持续牵引,玻璃体黄斑牵引综合征可引起黄斑水肿、囊样变性、劈裂等多种病变。目前,非手术治疗主要为随访观察,在手术治疗方面,除传统的玻璃体切除术外,研究者们同样探索了诸如眼部按摩以及玻璃体内注射不同种类的气体或药物等方法,旨在实现玻璃体黄斑牵引的松解。但这些治疗方法的有效性尚缺乏充分证据,未来需要更多大型临床试验进行评估。本文综述了玻璃体黄斑牵引综合征的治疗及研究进展。Due to the constant traction of the residual vitreous on the macula,vitreomacular traction syndrome can result in various lesions,including macular edema,cystoid degeneration,and splitting.Currently,non-surgical treatments primarily involve regular follow-up observations.In terms of surgical interventions,in addition to the traditional vitrectomy,researchers have also explored methods such as ocular massage and intravitreal injections of different types of gases or drugs in order to achieve the release of vitreomacular traction.However,the effectiveness of these treatments lacks sufficient evidence,and further largescale clinical trials are needed to evaluate them in the future.This article provides a review of the treatment of vitreomacular traction syndrome and discusses the current progress in research.

关 键 词：综合征 玻璃体脱离 黄斑水肿 视网膜穿孔 

分 类 号：R68[医药卫生—骨科学]